Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

By Catapano Alberico L.   Davidson Michael H.   Ballantyne Christie M.   Brady William E.   Gazzara Russell A.   Tomassini Joanne E.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2041-2053

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico

By Briseño Germán Gómez   Mino-León Dolores  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1075-1081

Informa Healthcare

Access to resources Recommend Favorite

Begin with the Real-world Patients of Non-goal-achieved Hypercholesterolemia in Taiwan through the Ezetimibe/Simvastatin Tablet –– The BRAVO Study

By Huang Jui-Chu   Lee Tao-Yu   Liou Miaw-Jene   Lin Chi-Min   Pei Dee   Chen Zhih-Cherng   Liu Rue-Tsuan   Kwok Ching-Fai  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1645-1651

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Platelet and Inflammatory Biomarkers in Patients with Metabolic Syndrome

By  

Cardiology, Vol. 125, Iss. 2, 2013-05 ,pp. : 74-77

Karger

Access to resources Recommend Favorite

Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 34, Iss. 5, 2016-10 ,pp. : 371-382

John Wiley & Sons Inc

Access to resources Recommend Favorite